| 000 | 01712 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515170256.0 | ||
| 264 | 0 | _c20090623 | |
| 008 | 200906s 0 0 eng d | ||
| 022 | _a1526-632X | ||
| 024 | 7 |
_a10.1212/WNL.0b013e3181a2e8f6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCentonze, D | |
| 245 | 0 | 0 |
_aAltered anandamide degradation in attention-deficit/hyperactivity disorder. _h[electronic resource] |
| 260 |
_bNeurology _cApr 2009 |
||
| 300 |
_a1526-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAmidohydrolases _xanalysis |
| 650 | 0 | 4 |
_aArachidonic Acids _xanalysis |
| 650 | 0 | 4 |
_aAttention Deficit Disorder with Hyperactivity _xblood |
| 650 | 0 | 4 |
_aBrain _xenzymology |
| 650 | 0 | 4 |
_aCannabinoid Receptor Modulators _xanalysis |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 |
_aDopamine Plasma Membrane Transport Proteins _xmetabolism |
| 650 | 0 | 4 |
_aDown-Regulation _xphysiology |
| 650 | 0 | 4 | _aEndocannabinoids |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphocytes _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeural Pathways _xmetabolism |
| 650 | 0 | 4 |
_aPhospholipase D _xanalysis |
| 650 | 0 | 4 |
_aPolyunsaturated Alkamides _xanalysis |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 700 | 1 | _aBari, M | |
| 700 | 1 | _aDi Michele, B | |
| 700 | 1 | _aRossi, S | |
| 700 | 1 | _aGasperi, V | |
| 700 | 1 | _aPasini, A | |
| 700 | 1 | _aBattista, N | |
| 700 | 1 | _aBernardi, G | |
| 700 | 1 | _aCuratolo, P | |
| 700 | 1 | _aMaccarrone, M | |
| 773 | 0 |
_tNeurology _gvol. 72 _gno. 17 _gp. 1526-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/WNL.0b013e3181a2e8f6 _zAvailable from publisher's website |
| 999 |
_c18828955 _d18828955 |
||